SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-18-004793
Filing Date
2018-07-09
Accepted
2018-07-09 16:39:25
Documents
2
Period of Report
2018-07-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 g791808k.htm 8-K 24262
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 7345
  Complete submission text file 0001214659-18-004793.txt   32829
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 18945086
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1